As of June 30, 2026, Alzinova AB carries a market capitalization of 97.42M, placing it among publicly traded companies globally. Its enterprise value stands at 84.11M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 97.42M |
| Enterprise Value | 84.11M |
Alzinova AB's next confirmed earnings release is scheduled for November 12, 2026.
| Earnings Date | 11/12/2026 |
As of June 30, 2026, Alzinova AB has 202.64M shares outstanding.
| Shares Outstanding | 202.64M |
These figures are as of June 30, 2026.
| PB Ratio | 0.62 |
| P/TBV Ratio | 14.39 |
| P/FCF Ratio | -1.35 |
| P/OCF Ratio | -2.41 |
As of June 30, 2026, Alzinova AB maintains a current ratio of 2.11, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.11 |
| Quick Ratio | 1.96 |
| Interest Coverage | -11.80 |
Over the twelve months ended June 30, 2026, Alzinova AB posted a negative return on equity (ROE) of -16.70, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -15.81, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -16.70 |
| Return on Assets (ROA) | -15.81 |
| Employee Count | 2.00 |
As of the close on October 22, 2026, Alzinova AB's stock has declined approximately 68.95% over the past 52 weeks. The 50-day moving average sits at 0.59, while the 200-day moving average is 0.62.
| 52-Week Price Change | -68.95% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.62 |
Over the twelve months ended June 30, 2026, Alzinova AB generated - - in revenue and converted that into -24.29M in net income, yielding earnings per share of -0.20. EBITDA reached -22.48M, while operating income came in at -22.51M.
| Gross Profit | 15.05M |
| Operating Income | -22.51M |
| Pretax Income | -24.29M |
| Net Income | -24.29M |
| EBITDA | -22.48M |
| EBIT | -22.48M |
| Earnings Per Share (EPS) | -0.20 |
These figures are as of June 30, 2026. Total book value stands at 155.97M, with working capital of 7.57M providing operational flexibility.
| Cash & Cash Equivalents | 13.31M |
| Net Debt | -13.31M |
| Equity (Book Value) | 155.97M |
| Book Value Per Share | 0.77 |
| Working Capital | 7.57M |
Alzinova AB produced -23.75M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -19.92M in capital expenditures, free cash flow totaled -43.67M - equivalent to -0.37 per share.
| Operating Cash Flow | -23.75M |
| Capital Expenditures | -19.92M |
| Free Cash Flow | -43.67M |
| FCF Per Share | -0.37 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -74.05: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -46.67, meaning Alzinova AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -46.67 |
| FCF Yield | -74.05 |
Alzinova AB's most recent stock split took place on September 17, 2026.
| Last Split Date | 9/17/2026 |
As of June 30, 2026, Alzinova AB has an Altman Z-Score of -23.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -23.07 |
Already premium?